James Christensen
2016
In 2016, James Christensen earned a total compensation of $1.7M as Senior Vice President and Chief Scientific Officer at Mirati Therapeutics, a 78% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $84,048 |
|---|---|
| Option Awards | $1,310,348 |
| Salary | $350,051 |
| Other | $2,831 |
| Total | $1,747,278 |
Christensen received $1.3M in option awards, accounting for 75% of the total pay in 2016.
Christensen also received $84K in non-equity incentive plan, $350.1K in salary and $2.8K in other compensation.
Rankings
In 2016, James Christensen's compensation ranked 5,514th out of 14,075 executives tracked by ExecPay. In other words, Christensen earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,514 out of 14,075 | 61st |
Division Manufacturing | 1,983 out of 5,489 | 64th |
Major group Chemicals And Allied Products | 630 out of 1,895 | 67th |
Industry group Drugs | 471 out of 1,538 | 69th |
Industry Pharmaceutical Preparations | 374 out of 1,176 | 68th |
Source: SEC filing on April 20, 2017.
Christensen's colleagues
We found five more compensation records of executives who worked with James Christensen at Mirati Therapeutics in 2016.
2016
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2016
Mark Gergen
Mirati Therapeutics
Former Executive Vice President and Chief Operations Officer
2016
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2016
Jamie Donadio
Mirati Therapeutics
Chief Financial Officer
2016
Chris LeMasters
Mirati Therapeutics